California AB554 mandates coverage for FDA-approved antiretroviral drugs, devices, and products for HIV prevention without cost-sharing.

California AB554, known as the PrEPARE Act, requires nongrandfathered health insurance policies and health care service plans to cover FDA-approved antiretroviral drugs, devices, and products for HIV preexposure prophylaxis without imposing any cost-sharing. It prohibits these entities from subjecting these medically necessary drugs to prior authorization or step therapy, except when therapeutic equivalents are available. The act also mandates coverage for services provided by pharmacists for preexposure and postexposure prophylaxis, including related testing.

California AB554 mandates coverage for FDA-approved antiretroviral drugs, devices, and products for HIV prevention without cost-sharing.

California AB554, known as the PrEPARE Act, requires nongrandfathered health insurance policies and health care service plans to cover FDA-approved antiretroviral drugs, devices, and products for HIV preexposure prophylaxis without imposing any cost-sharing. It prohibits these entities from subjecting these medically necessary drugs to prior authorization or step therapy, except when therapeutic equivalents are available. The act also mandates coverage for services provided by pharmacists for preexposure and postexposure prophylaxis, including related testing.